The TSA process starts with the binding of an HRP-conjugated antibody to the target antigen. The HRP enzyme then catalyzes the conversion of tyramide into a highly reactive free radical. These radicals covalently bind to nearby tyrosine residues on proteins, effectively "tagging" the location of the antigen. This tagging can be visualized using a fluorescent or chromogenic substrate, significantly amplifying the signal.